Downhill Walking in IPF

Launched by SAGLIK BILIMLERI UNIVERSITESI · Dec 25, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Downhill Walking in IPF," aims to investigate how walking downhill can affect people with Idiopathic Pulmonary Fibrosis (IPF). The researchers want to see if this type of exercise can improve patients' ability to exercise, their quality of life, and their blood lactate levels, which can indicate how hard the body is working during physical activity. After an initial assessment, participants will be placed into two groups: one will do downhill walking as part of a rehabilitation program, while the other will follow a standard rehabilitation program.

To be eligible for this trial, participants need to be between 18 and 75 years old and must have a confirmed diagnosis of IPF. They should be able to walk on a treadmill and haven't participated in a structured exercise program for the last six months. Participants will be asked to commit to attending a series of rehabilitation sessions. It’s important to note that individuals with certain severe heart conditions or other significant health issues may not be able to join. This study is not yet recruiting participants, but it’s a great opportunity for those looking to explore new ways to enhance their health and well-being while living with IPF.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having a diagnosis of IPF according to the clinical diagnostic criteria of the American Thoracic Society and/or the European Respiratory Society (ATS-ERS).
• • Being between the ages of 18 and 75.
• • Being able to walk on a treadmill.
• • Having the ability to cooperate.
• • No change in current medication in the last month.
• • Not participating in a structured activity program for at least six months.
• • Accepting the purpose and method of this study voluntarily and give informed consent for the study.
• Exclusion Criteria:
• • Presence of physical or mental impairment that prevents informed consent or compliance with the protocol.
• • Inability to attend more than 20% of pulmonary rehabilitation sessions.
• • Presence of major cardiovascular disease (coronary artery disease, uncontrolled hypertension, arrhythmias, or heart failure).
• • Presence of existing orthopedic and neuromuscular exercise limitations.
• • Acute exacerbation